| Literature DB >> 33924612 |
Ping-Chung Kuo1, Yue-Chiun Li1, Anjar M Kusuma1, Jason T C Tzen2, Tsong-Long Hwang3,4,5, Guan-Hong Ye1, Mei-Lin Yang1, Sheng-Yang Wang6.
Abstract
Pinus needle tea are very popular in Eastern countries such as Japan, Russia, Korea, and China. Pine needle tea is claimed to have significant anti-aging effects, but no clear evidence has supported this until now. In the present study, five undescribed compounds (1-5) as well as seventy-two known compounds were purified and characterized from the bioactive fraction of methanol extracts of P. taiwanensis needles. Most of the isolates were examined for their anti-inflammatory bioactivity by cellular neutrophil model and six compounds (45, 47, 48, 49, 50, and 51) exhibited a significant inhibition on superoxide anion generation and elastase release with IC50 values ranging from 3.3 ± 0.9 to 8.3 ± 0.8 μM. These anti-inflammatory ingredients were subjected to docking computing to evaluate their binding affinity on the ghrelin receptor, which played an important role in regulating metabolism, with anti-aging effects. Compounds 49, 50, and 51 formed a stable complex with the ghrelin receptor via hydrogen bonds and different types of interactions. These results suggest the flavonoids are responsible for the potential anti-aging effects of pine needle tea.Entities:
Keywords: Pinaceae; Pinus taiwanensis; anti-inflammatory; elastase release; ghrelin receptor; molecular docking; superoxide anion generation
Year: 2021 PMID: 33924612 PMCID: PMC8069155 DOI: 10.3390/antiox10040598
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
1H and 13C NMR spectroscopic data of compounds 1 and 2.
| Position | 1 | 2 | ||
|---|---|---|---|---|
|
|
| |||
| 1 | – | 162.1 | – | 150.2 |
| 2 | 6.86 (2H, d, | 116.3 | – | 148.1 |
| 3 | 7.83 (2H, d, | 132.0 | 7.45 (1H, d, | 118.3 |
| 4 | – | 116.1 | – | 132.4 |
| 5 | 7.83 (2H, d, | 132.0 | 7.38 (1H, dd, | 122.5 |
| 6 | 6.86 (2H, d, | 116.3 | 6.96 (1H, d, | 116.5 |
| 7 | – | 175.4 | – | 174.4 |
| 1′ | – | 133.5 | – | 134.0 |
| 2′ | 7.24 (2H, d, | 129.2 | 7.02 (1H, d, | 111.4 |
| 3′ | 6.72 (2H, d, | 115.9 | – | 148.9 |
| 4′ | – | 157.9 | – | 147.2 |
| 5′ | 6.72 (2H, d, | 115.9 | 6.74 (1H, d, | 115.9 |
| 6′ | 7.24 (2H, d, | 129.2 | 6.84 (1H, dd, | 120.6 |
| 7′ | 4.85 (1H, d, | 73.8 | 4.93 (1H, d, | 73.8 |
| 8′ | 4.48 (1H, m) | 84.1 | 4.33 (1H, m) | 86.3 |
| 9′ | 3.81 (1H, dd, | 62.0 | 3.55 (1H, dd, | 61.7 |
| OCH3-3′ | – | – | 3.81 (3H, s) | 56.3 |
1H- and 13C-NMR data (δ in ppm) were measured in CD3OD at 400 and 100 MHz. “s”, “d”, “m”, and “dd” were for the singlet, doublet, multiplet, and doublet of doublet signals, respectively.
Figure 1Structures of compounds 1–5 isolated from P. taiwanensis.
Inhibitory effects of purified compounds on superoxide anion generation and elastase release by human neutrophils in response to fMLF/CB.
| Compound | Superoxide Anion Generation | Elastase Release | ||
|---|---|---|---|---|
| IC50 (μM) a | Inh % b | IC50 (μM) | Inh % | |
|
| 6.4 ± 0.7 | 70.5 ± 6.8 *** | – c | 34.2 ± 6.9 ** |
|
| 6.0 ± 1.1 | 71.8 ± 8.1 *** | – | 43.5 ± 6.9 *** |
|
| 3.3 ± 0.9 | 87.5 ± 5.4 *** | 5.3 ± 0.2 | 93.9 ± 5.2 *** |
|
| 7.7 ± 0.9 | 60.6 ± 3.9 *** | – | 40.3 ± 6.0 ** |
|
| 5.3 ± 1.1 | 72.9 ± 6.3 *** | 5.8 ± 0.9 | 81.4 ± 12.0 *** |
|
| – | 45.2 ± 5.6 *** | 8.3 ± 0.8 | 57.0 ± 4.6 *** |
| LY294002 d | 1.1 ± 0.3 | 100.6 ± 1.0 *** | 3.2 ± 1.0 | 76.7 ± 6.8 *** |
Results are presented as mean ± SEM (n = 3-5). ** p < 0.01, *** p < 0.001 compared with the control (DMSO). a Concentration necessary for 50% inhibition (IC50). b Percentage of inhibition (Inh %) at 10 μM concentration. c Not determined. d A phosphatidylinositol-3-kinase inhibitor was used as a positive control.
Figure 2Structures of anti-inflammatory principles 45, 47, 48, 49, 50, and 51.
Binding energies of compound 45–51, and GHRP-6 calculated In Silico.
| Compound | Affinity (kcal/mol) |
|---|---|
|
| −8.8 |
|
| −8.2 |
|
| −8.2 |
|
| −10.5 |
|
| −11.0 |
|
| −10.7 |
| GHRP-6 | −10.3 |
Figure 3In Silico modeling of (A) GHRP-6, (B) 49, (C) 50, and (D) 51 docking into the ghrelin receptor.